ESC Heart Failure, 2024
Histological assessment of cardiac amyloidosis in patients undergoing transcatheter aortic valve replacement

Beuthner B., Elkenani M., Evert K. et al.

Translational Oncology, 2024
CT-guided high dose rate brachytherapy can induce multiple systemic proteins of proliferation and angiogenesis predicting outcome in HCC

Salvermoser L., Goldberg S., Alunni-Fabbroni M. et al.

Journal of Clinical Periodontology, 2024
LIGHT protein: A novel gingival crevicular fluid biomarker associated with increased probing depth after periodontal surgery

Esberg A., Kindstedt E., Isehed C. et al.

Journal of Clinical Immunology, 2024
Thymic Atrophy and Immune Dysregulation in Infants with Complex Congenital Heart Disease

Bremer S., Boxnick A., Glau L. et al.

International Journal of Cancer, 2024
Exploring causal correlations between circulating levels of cytokines and colorectal cancer risk: A Mendelian randomization analysis

Meng C., Sun L., Shi J. et al.

World Journal of Urology, 2024
Systemic interrogation of immune-oncology-related proteins in patients with locally advanced prostate cancer undergoing androgen deprivation and intensity-modulated radiotherapy

Guldvik I., Ramberg H., Kristensen G. et al.

Arteriosclerosis, Thrombosis, and Vascular Biology, 2024
Differences in Cardiometabolic Proteins in Pregnancy Prioritize Relevant Targets of Preeclampsia

Lindley K., Perry A., Jacobs M. et al.

Frontiers in Immunology, 2024
Vitreous Olink proteomics reveals inflammatory biomarkers for diagnosis and prognosis of traumatic proliferative vitreoretinopathy

Guo H., Wang T., Yu J. et al.

Frontiers in Immunology, 2024
Evaluating the effects of circulating inflammatory proteins as drivers and therapeutic targets for severe COVID-19

Baranova A., Luo J., Fu L. et al.

Nature Communications, 2024
Converging and evolving immuno-genomic routes toward immune escape in breast cancer

Blanco-Heredia J., Souza C., Trincado J. et al.

Molecular Cancer, 2024
Reshaping the tumor microenvironment of cold soft-tissue sarcomas with oncolytic viral therapy: a phase 2 trial of intratumoral JX-594 combined with avelumab and low-dose cyclophosphamide

Toulmonde M., Guegan J., Spalato-Ceruso M. et al.

Acta Biomaterialia, 2024
Increased matrix stiffness enhances pro-tumorigenic traits in a physiologically relevant breast tissue- monocyte 3D model

Abrahamsson A., Boroojeni F., Naeimipour S. et al.

Annals of the Rheumatic Diseases, 2024
Systemic inflammatory cytokine profiles in patients with gout during flare, intercritical and treat-to-target phases: TNFSF14 as new biomarker

Ea H., Kischkel B., Chirayath T. et al.

Dermatology and Therapy, 2024
Inhibition of Receptor-Interacting Protein Kinase 1 in Chronic Plaque Psoriasis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

Ludbrook V., Budd D., Thorn K. et al.

Journal of Autoimmunity, 2024
The enigma of sclera-specific autoimmunity in scleritis

Vergouwen D., van Beek A., de Hoog J. et al.

Computers in Biology and Medicine, 2024
Exploring metformin monotherapy response in Type-2 diabetes: Computational insights through clinical, genomic, and proteomic markers using machine learning algorithms

Villikudathil A., Mc Guigan D., English A.

Advances in Rheumatology, 2024
Inflammatory cytokines and their potential role in Sjogren’s syndrome risk: insights from a mendelian randomization study

Shi W., Xu Y., Zhang A. et al.

Cardiovascular Diabetology, 2024
Association of plasma angiogenin with risk of major cardiovascular events in type 2 diabetes

Gurung R., Liu S., Liu J. et al.

Frontiers in Immunology, 2024
Exploring candidate biomarkers for rheumatoid arthritis through cardiovascular and cardiometabolic serum proteome profiling

Cuesta-López L., Escudero-Contreras A., Hanaee Y. et al.

Mechanisms of Ageing and Development, 2024
Common and distinct metabolomic markers related to immune aging in Western European and East African populations

Bulut O., Temba G., Koeken V. et al.